Kovitz Investment Group Partners’s Checkpoint Therapeutics CKPT Stock Holding History

Kovitz Investment Group Partners’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,000	Closed	-$64.6K	–	1361
2025 Q1	$64.6K	Buy	+16,000	New	+$53.3K	﹤0.01%	1226

Kovitz Investment Group Partners's CKPT Position: Q2 2025 in Review

Kovitz Investment Group Partners sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 16,000 shares — an estimated $64.6K sold.

Kovitz Investment Group Partners first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $64.6K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Kovitz Investment Group Partners reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Kovitz Investment Group Partners sold 16,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $64.6K.
Kovitz Investment Group Partners first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Kovitz Investment Group Partners's Checkpoint Therapeutics position peaked at $64.6K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Kovitz Investment Group Partners's 13F filing for Q2 2025, filed 14 Aug 2025.